Tradestie Institutional Equity Comparison Engine

ADMA vs CRSP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADMA Overall Edge

ADMA Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ADMA Biologics, Inc. (ADMA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ADMA trades at 15.7x Forward P/E with 44.9% operating margin (+5.1% YoY revenue) versus CRSP at 23.4x Forward P/E and -2058.6% operating margin (+1325.1% YoY). In options structure, ADMA sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro) against CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ADMA
ADMA 15.7x vs CRSP 23.4x Fwd P/E
Growth & Margin Winner ADMA
Op Margin 44.9% vs -2058.6% ยท YoY +5.1% vs +1325.1%
Momentum & Technical Winner ADMA
1Y -12.8% vs -20.5% ยท 52W Pos 49% vs 1%
Options & Structure Winner ADMA
SURGE (8th %ile IV) vs BREAKDOWN (52nd %ile IV)
ADMA NASDAQ
ADMA Biologics, Inc.
Biological Products, (No Disgnostic Substances)
$13.70
+0.11% 1D
Market Cap $2.9B
1M Return +28.23%
1Y Return -12.77%
Forward P/E 15.7x
Unified AI Score
23.7 / 100 STRONG SELL
Tech 50.0 Fund 35.0 Flow 66.0 Mom 25.9
CRSP NASDAQ
CRISPR Therapeutics AG
Biological Products, (No Disgnostic Substances)
$40.61
-3.86% 1D
Market Cap $4.1B
1M Return -17.54%
1Y Return -20.54%
Forward P/E 23.4x
Unified AI Score
44.7 / 100 HOLD
Tech 25.0 Fund 52.0 Flow 68.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADMA -12.77% CRSP -20.54% Spread: +7.77 pp (ADMA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ADMA Revenue CRSP Revenue ADMA Op. Margin CRSP Op. Margin Margin Edge
FY2018 $20M $0M -354.9% -5087.8% ADMA
FY2019 $30M $290M -141.1% 16.1% CRSP
FY2020 $40M $0M -153.8% -49295.5% ADMA
FY2021 $80M $910M -72.1% 40.8% CRSP
FY2022 $150M $0M -25.5% -56190.4% ADMA
FY2023 $260M $370M 8.4% -60.0% ADMA
FY2024 $430M $40M 32.6% -1250.4% ADMA
FY2025 $510M $0M 37.5% -18933.6% ADMA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADMA (6) vs CRSP (4)
Institutional Metric ADMA CRSP Criterion Row Winner
Market Capitalization Scale $2.9B $4.1B Larger Scale CRSP
Trailing P/E Ratio Valuation 17.2x 23.4x Lower Multiple ADMA
Forward P/E Ratio Valuation 15.7x 23.4x Lower Multiple ADMA
Revenue Growth (YoY) Growth +5.1% +1325.1% Higher Growth CRSP
Operating Margin (TTM) Profitability 44.9% -2058.6% Higher Margin ADMA
Net Profit Margin Profitability 35.1% 0.0% Higher Margin ADMA
Return on Equity (ROE) Capital Efficiency 41.9% -25.6% Higher ROE ADMA
52-Week Range Position Momentum 49% ($7โ€“$20) 1% ($40โ€“$63) Stronger Trend ADMA
Beta / 30D Volatility Risk Regime -0.42ฮฒ ยท 99% Vol 1.85ฮฒ ยท 60% Vol Lower Realized Risk CRSP
Unified Institutional Score Composite Signal 23.7 / 100 (STRONG SELL) 44.7 / 100 (HOLD) Higher Composite CRSP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADMA vs CRSP Buy Guide
ADMA SURGE
7d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ADMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRSP BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CRSP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADMA nor CRSP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.